GO:0003062 regulation of heart rate by chemical signal: Chemical Cardiac Chronotropy, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003062 (regulation of heart rate by chemical signal) describes how hormones, autacoids, paracrine and autocrine factors modulate the rate of cardiac contraction, distinct from purely neural chronotropic control.
• Peptidic and non-peptidic chemical signals interact bidirectionally with the autonomic nervous system to set heart rate, making this process a convergence point for endocrine and neural inputs.
• Drugs and environmental toxicants such as amitriptyline, stimulants of abuse, arsenic trioxide and bisphenol P can perturb chemical chronotropy and provoke arrhythmias or cardiotoxicity.
• Thyronamines and other endogenous amines act as chemical signals that can produce profound, sometimes opposite, effects on heart rate compared with classical thyroid hormones.
• Autonomic and chemical regulation of heart rate can be monitored non-invasively through heart rate variability and fetal heart rate signal analysis, providing translational readouts.
• CRISPR knockout, point-mutation, knock-in and overexpression models enable causal dissection of the receptors, ion channels and signaling enzymes that mediate chemical chronotropy.
Description
The rate at which the heart contracts is not fixed; it is continuously adjusted by chemical signals that include circulating hormones, locally released autacoids, and paracrine or autocrine factors. The Gene Ontology term GO:0003062, regulation of heart rate by chemical signal, captures this chemical arm of cardiac chronotropic control, explicitly separating it from the neural regulation that dominates rapid beat-to-beat adjustments. The term is defined as the regulation of the rate of heart contraction mediated by chemical signaling, hormonal, autocrine or paracrine, and it carries synonyms such as chemical cardiac chronotropy and chemical signal regulation of heart contraction rate. Understanding this process is essential because chemical chronotropy determines baseline heart rate, shapes the response to stress and exercise, and is a major target of cardiovascular and non-cardiovascular drugs. Mechanistically, chemical signals act on sinoatrial node pacemaker cells and on the conduction system by modulating ion channels, G-protein-coupled receptor signaling, and intracellular second messengers. Peptidic regulators such as natriuretic peptides, angiotensin II, endothelins and vasoactive intestinal peptide interact with the autonomic nervous system, so chemical and neural chronotropy are not independent but mutually reinforcing or opposing. Beyond peptides, small molecules including catecholamines, thyronamines, and numerous xenobiotics can shift heart rate by acting on adrenergic, cholinergic, thyroid hormone-like or other receptors. For researchers, GO:0003062 provides a structured framework to annotate genes and pathways that convert a chemical stimulus into a change in beating frequency. It is relevant to cardiotoxicity screening, autonomic physiology, fetal heart rate monitoring, and drug safety pharmacology. Because the process is experimentally tractable in cell models, isolated cardiomyocytes, and whole animals, it is well suited to CRISPR-based causal genetics and high-throughput chemical screens.
regulation of heart rate by chemical signal At A Glance
| GO ID | GO:0003062 |
|---|---|
| GO term | regulation of heart rate by chemical signal |
| Ontology | biological_process |
| Synonym | chemical cardiac chronotropy; chemical signal regulation of heart contraction rate; chemical signal regulation of heart rate |
| Major function | Modulation of the rate of heart contraction by hormones, autacoids, and paracrine or autocrine chemical signals |
| Cellular context | Sinoatrial node pacemaker cells, conduction system myocytes, and cardiomyocytes |
| Key signal types | Peptidic hormones, catecholamines, thyronamines, and xenobiotic cardiotoxicants |
| Related physiological readouts | Heart rate variability, fetal heart rate patterns, QT interval |
| Disease relevance | Arrhythmia, drug-induced cardiotoxicity, autonomic dysfunction |
What Is GO:0003062?
In simple terms, GO:0003062 describes how chemicals in the blood or released locally tell the heart to speed up or slow down. Formally, it is the biological process in which the rate of heart contraction is regulated by chemical signaling, including hormonal, autocrine and paracrine signals. It excludes regulation that occurs purely through direct neural wiring, although in practice chemical and neural signals interact. The term covers the sensing of a chemical cue, the intracellular signaling it triggers in pacemaker and conduction cells, and the resulting change in the frequency of contraction.
Why Is regulation of heart rate by chemical signal Important in Cell Biology?
Chemical regulation of heart rate is important because it sets the baseline chronotropic state of the heart and determines how the organ responds to hormones, stress, drugs, and environmental exposures. Unlike rapid neural reflexes, chemical signals can produce sustained changes in heart rate and can act directly on pacemaker cells, so they are central to conditions such as drug-induced arrhythmia, autonomic dysfunction, and fetal distress. Because many chemical chronotropic pathways are druggable or measurable, GO:0003062 is a productive entry point for both mechanistic cardiovascular research and safety pharmacology.
• Defines the chemical arm of heart rate control, complementing neural chronotropy.
• Explains how hormones and autacoids set baseline and stress-responsive heart rate.
• Underlies drug-induced changes in heart rate and QT interval, as seen with amitriptyline.
• Contributes to arrhythmia risk from stimulant drugs of abuse.
• Mediates cardiotoxicity of environmental agents such as arsenic trioxide and bisphenol P.
• Provides a framework for interpreting heart rate variability and autonomic balance.
• Supports fetal heart rate monitoring and obstetric decision-making.
• Offers tractable targets for CRISPR-based causal gene validation in cardiomyocyte models.
• Enables high-throughput chemical screening for chronotropic and cardiotoxic compounds.
• Connects endocrine physiology, cardiac electrophysiology, and toxicology in one annotation.
What Happens During regulation of heart rate by chemical signal?
Chemical signal availability and delivery
In simple terms: First, a chemical signal has to reach the heart.
The process begins when a chemical signal such as a peptide hormone, catecholamine, thyronamine, or xenobiotic is present in the circulation or released locally by cardiac or endothelial cells. Peptidic regulators of heart rate include natriuretic peptides, angiotensin II, endothelin-1 and vasoactive intestinal peptide, which can act on the heart and also interact with the autonomic nervous system. Thyronamines represent another class of endogenous chemical signals with chronotropic potential. The concentration, stability and delivery of these signals determine the magnitude of the subsequent heart rate change.
Receptor sensing on pacemaker and conduction cells
In simple terms: The signal docks onto receptors on the heart's pacemaker cells.
Once delivered, the chemical signal binds to receptors expressed on sinoatrial node pacemaker cells, conduction system myocytes, and working cardiomyocytes. These receptors include G-protein-coupled receptors for peptides and catecholamines, as well as nuclear receptors for thyroid hormone-like molecules. The interaction between peptidic signals and the autonomic nervous system means that receptor-level integration can either amplify or dampen the chronotropic response. Stimulant drugs of abuse similarly engage adrenergic and other receptors to alter heart rate and provoke arrhythmias.
Intracellular signaling and second messengers
In simple terms: Inside the cell, the signal triggers a cascade of molecular messengers.
Receptor activation initiates intracellular signaling cascades, including G-protein-mediated changes in cyclic AMP, calcium handling, and kinase activity. These cascades converge on the ion channels and transporters that generate the pacemaker potential, thereby shifting the slope of diastolic depolarization and the firing rate of sinoatrial node cells. Chemical signals can also act through autocrine and paracrine loops, meaning that cardiomyocytes and neighboring cells release factors that feed back on the pacemaker. The interplay between hormonal, autocrine and paracrine signaling is explicitly part of the GO:0003062 definition.
Electrophysiological output and heart rate change
In simple terms: The end result is a faster or slower heartbeat.
The integrated signaling modifies the activity of ion channels such as HCN, calcium, and potassium channels, changing the frequency of action potential generation in the sinoatrial node. This produces a measurable change in heart rate, which can be recorded as heart rate variability, QT interval, or fetal heart rate patterns. Drug-induced increases in heart rate and QTc, for example with amitriptyline, illustrate how chemical signals translate into electrophysiological and clinical readouts. Cardiotoxicants such as arsenic trioxide and bisphenol P can disrupt these outputs and lead to arrhythmia or cardiac injury.
Integration with neural and systemic control
In simple terms: Chemical signals do not work alone; they talk to the nervous system.
Chemical chronotropy is integrated with autonomic neural control. Peptidic regulators of heart rate interact with the autonomic nervous system, so the same peptide can have different effects depending on sympathetic and parasympathetic tone. Stimulant drugs of abuse further illustrate the convergence of chemical and neural inputs on arrhythmia risk. This integration ensures that heart rate is matched to systemic demands, but it also means that chemical and neural perturbations can compound one another in disease.
Key Genes Involved in GO:0003062 regulation of heart rate by chemical signal
The genes and proteins below represent major nodes through which chemical signals regulate heart rate, spanning receptors, ion channels, signaling enzymes, and hormonal pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ADRB1 | Beta-1 adrenergic receptor mediating catecholamine chronotropy | Target for stimulant and drug effects on heart rate |
| ADRB2 | Beta-2 adrenergic receptor modulating cardiac and vascular responses | Relevant to autonomic and chemical heart rate regulation |
| CHRM2 | Muscarinic acetylcholine receptor mediating cholinergic slowing | Central to parasympathetic chemical chronotropy |
| HCN4 | Pacemaker channel carrying the funny current in sinoatrial node | Effector of chemical signals that change firing rate |
| SCN5A | Cardiac sodium channel influencing excitability and conduction | Arrhythmia and drug response studies |
| KCNH2 | Potassium channel underlying IKr and QT interval | Target of drug-induced QT and heart rate changes |
| KCNQ1 | Potassium channel contributing to repolarization | Relevant to chemical modulation of repolarization |
| NPPA | Natriuretic peptide precursor A, a peptidic cardiac hormone | Peptidic regulation of heart rate and autonomic interaction |
| NPPB | Natriuretic peptide precursor B, cardiac stress hormone | Biomarker and mediator in cardiotoxicity |
| EDN1 | Endothelin-1, a potent vasoactive and chronotropic peptide | Peptidic regulation of heart rate |
| AGTR1 | Angiotensin II receptor type 1 | Links renin-angiotensin signaling to heart rate |
| VIP | Vasoactive intestinal peptide | Peptidic chronotropic regulator interacting with autonomic tone |
| THRA | Thyroid hormone receptor alpha | Mediates thyroid hormone-like chemical chronotropy |
| THRB | Thyroid hormone receptor beta | Mediates thyroid hormone-like chemical chronotropy |
| GNAS | Stimulatory G-protein alpha subunit | Couples receptors to cAMP and pacemaker modulation |
| PRKACA | cAMP-dependent protein kinase catalytic subunit | Phosphorylates ion channels and calcium handling proteins |
| RYR2 | Ryanodine receptor 2, sarcoplasmic reticulum calcium release channel | Calcium-dependent modulation of heart rate and arrhythmia |
| ATP2A2 | SERCA2 calcium pump | Controls calcium reuptake and pacemaker cell calcium cycling |
How Is regulation of heart rate by chemical signal Regulated?
The process of chemical regulation of heart rate is itself regulated at multiple levels. Receptor density and sensitivity, G-protein coupling efficiency, and the balance between stimulatory and inhibitory second messengers determine how strongly a given chemical signal changes heart rate. Peptidic regulators interact with the autonomic nervous system, so autonomic tone can set the gain of chemical chronotropy. Circulating concentrations of hormones and drugs, as shown for amitriptyline, correlate with the magnitude of heart rate and QTc changes. Stimulant drugs of abuse can override normal regulatory feedback and precipitate arrhythmias. Environmental toxicants such as arsenic trioxide and bisphenol P can dysregulate the signaling and apoptotic pathways that normally protect cardiac rhythm. Finally, thyroid hormone-like signals such as thyronamines can produce distinct and sometimes opposing chronotropic effects compared with classical thyroid hormones, adding another layer of regulation.
regulation of heart rate by chemical signal and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| KCNH2 | Drug-induced QT prolongation and arrhythmia | Knockout or point-mutation cardiomyocyte model |
| SCN5A | Stimulant-associated arrhythmia and conduction abnormalities | Knock-in of patient variants in cardiomyocytes |
| NPPB | Cardiotoxicity and cardiac stress | Overexpression and knockout in cardiac cell lines |
| ADRB1 | Altered heart rate response to catecholamines | Knockout and point-mutation models |
| THRA | Thyroid hormone-like chronotropic effects | Knock-in of receptor variants and overexpression |
Drug-induced arrhythmia and QT prolongation
Chemical regulation of heart rate is directly implicated in drug-induced arrhythmia. Amitriptyline increases heart rate and QTc in a manner correlated with serum concentration, demonstrating that a chemical signal can translate into clinically significant electrophysiological change. Stimulant drugs of abuse are also associated with cardiac arrhythmias through their effects on adrenergic signaling. These observations make GO:0003062 a useful annotation for safety pharmacology and for interpreting heart rate changes during drug development.
Cardiotoxicity from environmental and therapeutic agents
Arsenic trioxide is a well-documented cardiotoxicant that can cause QT prolongation and arrhythmia, reflecting disruption of chemical and electrophysiological heart rate control. High-throughput screening has identified bisphenol P as a potent cardiotoxin that induces cardiotoxicity through apoptosis and the NF-kB pathway. These examples show that exogenous chemicals can hijack the same signaling nodes that normally regulate heart rate, producing disease-relevant phenotypes.
Autonomic dysfunction and heart rate variability
Autonomic regulation of heart rate is closely linked to chemical chronotropy, and urine proteome changes have been associated with autonomic regulation of heart rate in cosmonauts, illustrating how systemic physiological states can be reflected in molecular signatures. Fetal heart rate signal analysis provides another window into chemical and neural control of heart rate in a clinical setting. Together, these approaches connect GO:0003062 to autonomic dysfunction and to monitoring strategies.
Endocrine and metabolic influences on heart rate
Thyronamines and related thyroid hormone-like molecules can modulate heart rate, expanding the endocrine dimension of chemical chronotropy. Peptidic regulators such as natriuretic peptides, endothelin-1 and angiotensin II further link endocrine and paracrine systems to cardiac rhythm. Dysregulation of these pathways may contribute to heart rate abnormalities in metabolic and endocrine disease, making GO:0003062 relevant beyond classical cardiology.
From regulation of heart rate by chemical signal-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate receptor required for chemical chronotropy? | CRISPR knockout in cardiomyocyte or pacemaker-like cell model |
| Does a specific point mutation alter ligand sensitivity? | CRISPR point mutation (base or prime editing) in the endogenous locus |
| Does a disease-associated variant change heart rate signaling? | Knock-in of the variant into the endogenous gene |
| Where and when is the protein expressed in cardiac cells? | Tagged knock-in with fluorescent or epitope tag |
| Does increased expression of a signaling gene change beating rate? | Overexpression via safe-harbor knock-in or lentiviral delivery |
| Which chemical compounds perturb heart rate signaling? | High-throughput chemical screening in CRISPR-perturbed cell models |
How to Study the regulation of heart rate by chemical signal Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Heart rate variability analysis | Autonomic and chemical modulation of beat-to-beat intervals | Human and animal physiology studies |
| Fetal heart rate signal processing | Fetal cardiac rhythm patterns | Obstetric monitoring and signal analysis |
| Patch-clamp electrophysiology | Ion channel currents in cardiomyocytes | Mechanistic validation of chemical chronotropy |
| QT interval measurement | Repolarization timing | Drug safety and arrhythmia risk assessment |
| Cyclic AMP and calcium imaging | Second messenger dynamics | Receptor signaling studies |
| High-throughput chemical screening | Compound effects on cardiac cells | Cardiotoxicity discovery |
| Proteomics of biofluids | Molecular signatures associated with heart rate regulation | Biomarker discovery |
| CRISPR perturbation followed by phenotyping | Causal gene contribution to heart rate signaling | Target validation in cell models |
Heart rate and heart rate variability analysis
Heart rate and its variability can be measured non-invasively in humans and animals, providing a direct readout of chemical and autonomic chronotropy. Autonomic regulation of heart rate has been associated with urine proteome changes in cosmonauts, showing that molecular and physiological measurements can be integrated. Fetal heart rate signal processing offers a specialized set of techniques for extracting rate patterns from noisy recordings.
Electrophysiology and QT interval assessment
Patch-clamp electrophysiology in isolated cardiomyocytes and electrocardiographic QT interval measurement in vivo or in vitro allow researchers to link chemical signals to ion channel function and repolarization. Drug studies such as the amitriptyline study demonstrate how serum concentration can be correlated with heart rate and QTc changes. These methods are essential for validating causal effects of genes identified through CRISPR screens.
Molecular signaling assays
Cyclic AMP, calcium imaging, kinase activity assays, and receptor binding assays can quantify the intracellular events triggered by chemical signals. Peptidic regulation of heart rate and its interaction with the autonomic nervous system has been studied using such approaches. Thyronamine research similarly relies on molecular assays to distinguish receptor-mediated effects.
High-throughput screening and toxicology
High-throughput screening can identify chemicals that perturb heart rate signaling or cause cardiotoxicity. Bisphenol P was identified as a potent cardiotoxin through such screening, with apoptosis and NF-kB pathway involvement. Arsenic trioxide cardiotoxicity studies provide another example of how toxicological methods connect chemical exposure to cardiac rhythm.
How CRISPR Can Be Used to Study GO:0003062 regulation of heart rate by chemical signal
Knockout
CRISPR knockout of candidate receptors, ion channels, or signaling enzymes in cardiomyocyte and pacemaker-like cell models can determine whether a gene is required for chemical regulation of heart rate. For example, knocking out ADRB1 or HCN4 would test their necessity in catecholamine or pacemaker signaling. Knockout models are also useful for validating hits from high-throughput cardiotoxicity screens.
Point Mutation
Point mutations introduced by base editing or prime editing allow precise testing of residues that control ligand binding, channel gating, or phosphorylation. This is particularly relevant for genes such as KCNH2 and SCN5A, where single amino acid changes can alter drug responses and arrhythmia risk. Point-mutation models help distinguish gain-of-function from loss-of-function mechanisms in chemical chronotropy.
Knock-in
Knock-in of disease-associated variants or reporter tags into endogenous loci provides physiologically regulated expression. Tagged knock-in can reveal where a signaling protein localizes in pacemaker and conduction cells. Variant knock-in models are valuable for studying how human genetic variation modifies the heart rate response to hormones, drugs, or toxicants.
Overexpression
Overexpression of a chemical signaling gene, for example NPPB or a constitutively active receptor, can test whether increased signaling is sufficient to change heart rate or to induce cardiotoxic phenotypes. Overexpression models complement knockout studies by establishing sufficiency rather than necessity. They are also useful for producing cell models with exaggerated responses for screening assays.
How EDITGENE Supports regulation of heart rate by chemical signal Research
Researchers studying regulation of heart rate by chemical signal-related genes often need to determine whether a candidate gene is causally involved in setting or modifying cardiac rhythm. Observational associations, expression changes, and chemical screens can nominate targets, but causal proof requires controlled genetic perturbation. EDITGENE provides the CRISPR tools and cell models needed to move from correlation to mechanism in this pathway.
Contact EDITGENE today to design your custom CRISPR model for regulation of heart rate by chemical signal research.
Frequently Asked Questions About regulation of heart rate by chemical signal
What is GO:0003062 regulation of heart rate by chemical signal?
GO:0003062 is a Gene Ontology biological process term describing how the rate of heart contraction is regulated by chemical signaling, including hormonal, autocrine and paracrine signals.
What genes are involved in regulation of heart rate by chemical signal?
Genes encoding adrenergic and muscarinic receptors, pacemaker ion channels such as HCN4, signaling enzymes such as GNAS and PRKACA, and hormonal peptides such as NPPA, NPPB, EDN1 and VIP are involved.
How is chemical regulation of heart rate different from neural regulation?
Chemical regulation acts through hormones, autacoids and paracrine factors, while neural regulation acts through direct autonomic innervation; the two interact closely.
Which drugs affect heart rate through chemical signaling?
Amitriptyline increases heart rate and QTc in a concentration-dependent manner, and stimulant drugs of abuse are associated with arrhythmias through adrenergic mechanisms.
Can environmental chemicals disrupt heart rate regulation?
Yes, arsenic trioxide and bisphenol P have been shown to cause cardiotoxicity and disrupt cardiac signaling.
What are thyronamines and how do they affect heart rate?
Thyronamines are endogenous thyroid hormone-like molecules that can modulate heart rate and have been reviewed as past, present and future endocrine signals.
How is heart rate variability related to chemical chronotropy?
Heart rate variability reflects autonomic and chemical modulation of beat-to-beat intervals and has been associated with molecular changes in biofluids.
What methods are used to study regulation of heart rate by chemical signal?
Methods include heart rate variability analysis, fetal heart rate signal processing, patch-clamp electrophysiology, QT measurement, second messenger assays, proteomics and high-throughput screening.
How can CRISPR help study GO:0003062?
CRISPR knockout, point mutation, knock-in and overexpression models allow causal testing of genes that mediate chemical effects on heart rate.
Why is fetal heart rate signal analysis relevant to this GO term?
Fetal heart rate patterns reflect chemical and neural control of cardiac rhythm and require specialized signal processing techniques.
Conclusion
GO:0003062 regulation of heart rate by chemical signal provides a precise ontology framework for the hormonal, autocrine and paracrine control of cardiac rhythm. It connects peptidic regulators, adrenergic and cholinergic signaling, ion channels, and endocrine molecules to measurable changes in heart rate, and it is directly relevant to drug-induced arrhythmia, cardiotoxicity, autonomic dysfunction and fetal monitoring. Because the pathway is experimentally tractable, CRISPR-based knockout, point-mutation, knock-in and overexpression models can establish causal roles for candidate genes and accelerate the discovery of safer therapeutics.
References
- 1. Beaulieu P et al.. 1998. Peptidic regulation of heart rate and interactions with the autonomic nervous system.. Cardiovasc Res 37(3):578-85 PMID: 9659441
- 2. Vineetha VP et al.. 2019. An Overview on Arsenic Trioxide-Induced Cardiotoxicity.. Cardiovasc Toxicol 19(2):105-119 PMID: 30617460
- 3. Pastushkova LH et al.. 2019. Urine proteome changes associated with autonomic regulation of heart rate in cosmonauts.. BMC Syst Biol 13(Suppl 1):17 PMID: 30836973
- 4. Wang J et al.. 2025. High-Throughput Screening Identifies Bisphenol P as a Potent Cardiotoxin, Inducing Cardiotoxicity through Apoptosis and the NF-κB Pathway.. Environ Sci Technol 59(29):14870-14880 PMID: 40570244
- 5. Unterecker S et al.. 2015. Increase of Heart Rate and QTc by Amitriptyline, But Not by Venlafaxine, Is Correlated to Serum Concentration.. J Clin Psychopharmacol 35(4):460-3 PMID: 26035054
- 6. Dominic P et al.. 2022. Stimulant Drugs of Abuse and Cardiac Arrhythmias.. Circ Arrhythm Electrophysiol 15(1):e010273 PMID: 34961335
- 7. Piehl S et al.. 2011. Thyronamines--past, present, and future.. Endocr Rev 32(1):64-80 PMID: 20880963
- 8. Ponsiglione AM et al.. 2021. A Comprehensive Review of Techniques for Processing and Analyzing Fetal Heart Rate Signals.. Sensors (Basel) 21(18) PMID: 34577342
